Kolb H J, Wündisch G F, Spitzer I, Ochsler H, Stengel-Rutkowski L, Bender-Götze C, Albert E D, Sauer H, Ledderose G, Brehm G, Jehn U, Eckstein R, Mempel W, Wilmanns W, Haas R J, Helmig M, Netzel B, Belohradsky B, Janka G, Rodt H, Grosse-Wilde H, Thiel E, von Lieven H, Roloff R, Krimmel B L, Bunde E, Wank R, Schendel D
Klin Wochenschr. 1981 Apr 1;59(7):325-42. doi: 10.1007/BF01525001.
From March 1975 until May 1980 twelve patients with severe aplastic anemia were grafted with bone marrow from HLA-identical siblings by the Munich Cooperative Group for Bone Marrow Transplantation. Six patients are alive between 10 months and more than 5 years after grafting with normal blood values and marrow. One patient is treated as an out patient for chronic localized graft-versus-host disease (GvHD), five patients are well and without treatment. Six patients have died, one patient with a cerebral hemorrhage the day before transplantation, three patients following rejection of grafts 32, 40 and 55 days after grafting, one patient with severe GvHD 85 days after grafting and one patient, probably with interstitial pneumonia, following cerebral hemorrhage. Three of 6 patients who were conditioned with Cyclophosphamide (CY) only died following rejection of the graft. Two adults who were conditioned with CY and "total lymphoid irradiation" and three children, who wer given unirradiated leukocyte concentrates from the marrow donor after grafting, did not reject their grafts. The results of the Munich-Cooperative Group for Bone Marrow Transplantation are comparable to those of large, specialized centers for bone marrow transplantation, they indicate possibilities of cure of severe aplastic anemia by marrow grafts from HLA-identical siblings. They confirm that better results are obtained with earlier transplantation in the course of the disease.
从1975年3月至1980年5月,慕尼黑骨髓移植协作组对12例严重再生障碍性贫血患者进行了 HLA 相同同胞的骨髓移植。6例患者在移植后10个月至5年多存活,血常规和骨髓值正常。1例患者作为门诊病人接受慢性局限性移植物抗宿主病(GvHD)治疗,5例患者情况良好且无需治疗。6例患者死亡,1例在移植前一天死于脑出血,3例在移植后32、40和55天因移植排斥反应死亡,1例在移植后85天死于严重的移植物抗宿主病,1例可能因脑出血并发间质性肺炎死亡。仅接受环磷酰胺(CY)预处理的6例患者中有3例在移植排斥后死亡。2例接受CY和“全身淋巴照射”预处理的成年人以及3例在移植后接受来自骨髓供体未照射白细胞浓缩物的儿童未发生移植排斥。慕尼黑骨髓移植协作组的结果与大型专业骨髓移植中心的结果相当,表明通过 HLA 相同同胞的骨髓移植治愈严重再生障碍性贫血具有可能性。他们证实,在疾病过程中早期移植可获得更好的结果。